These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17590556)

  • 1. Uncertainty of measurement and error in stability studies.
    Magari RT
    J Pharm Biomed Anal; 2007 Sep; 45(1):171-175. PubMed ID: 17590556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the performance of the ICH guidelines for shelf life estimation.
    Quinlan M; Stroup W; Schwenke J; Christopher D
    J Biopharm Stat; 2013; 23(4):881-96. PubMed ID: 23786363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple Approach to Calculate Random Effects Model Tolerance Intervals to Set Release and Shelf-Life Specification Limits of Pharmaceutical Products.
    Montes RO; Burdick RK; Leblond DJ
    PDA J Pharm Sci Technol; 2019; 73(1):39-59. PubMed ID: 30361286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shelf life determination based on equivalence assessment.
    Tsong Y; Chen WJ; Lin TY; Chen CW
    J Biopharm Stat; 2003 Aug; 13(3):431-49. PubMed ID: 12921392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of stability study designs.
    Lin TY; Chen CW
    J Biopharm Stat; 2003 Aug; 13(3):337-54. PubMed ID: 12921386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability analysis with discrete responses.
    Chow SC; Shao J
    J Biopharm Stat; 2003 Aug; 13(3):451-62. PubMed ID: 12921393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One- and two-stage Arrhenius models for pharmaceutical shelf life prediction.
    Fan Z; Zhang L
    J Biopharm Stat; 2015; 25(2):307-16. PubMed ID: 25358076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance levels for stability pooling test: a simulation study.
    Chen WJ; Tsong Y
    J Biopharm Stat; 2003 Aug; 13(3):355-74. PubMed ID: 12921387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating degradation in real time and accelerated stability tests with random lot-to-lot variation: a simulation study.
    Magari RT
    J Pharm Sci; 2002 Mar; 91(3):893-9. PubMed ID: 11920774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the shelf life of pharmaceutical products.
    Capen R; Christopher D; Forenzo P; Ireland C; Liu O; Lyapustina S; O'Neill J; Patterson N; Quinlan M; Sandell D; Schwenke J; Stroup W; Tougas T
    AAPS PharmSciTech; 2012 Sep; 13(3):911-8. PubMed ID: 22729779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjusting dissolution specifications for the variability induced by storage conditions.
    Reynolds JM; Rogers DH
    J Biopharm Stat; 2000 Aug; 10(3):425-31. PubMed ID: 10959921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the distribution of batch shelf lives.
    Quinlan M; Stroup W; Christopher D; Schwenke J
    J Biopharm Stat; 2013; 23(4):897-920. PubMed ID: 23786624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rank regression in stability analysis.
    Chen YQ; Pong A; Xing B
    J Biopharm Stat; 2003 Aug; 13(3):463-79. PubMed ID: 12921394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision of the reportable value-Statistical optimization of the number of replicates.
    Burdick RK; Ermer J
    J Pharm Biomed Anal; 2019 Jan; 162():149-157. PubMed ID: 30240988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement uncertainty and risk of false conformity decision in the performance evaluation of liquid chromatography analytical procedures.
    Separovic L; Lourenço FR
    J Pharm Biomed Anal; 2019 Jul; 171():73-80. PubMed ID: 30974411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined statistical analyses for long-term stability data with multiple storage conditions: a simulation study.
    Almalik O; Nijhuis MB; van den Heuvel ER
    J Biopharm Stat; 2014; 24(3):493-506. PubMed ID: 24697656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANCOVA approach for shelf life analysis of stability study of multiple factor designs.
    Tsong Y; Chen WJ; Chen CW
    J Biopharm Stat; 2003 Aug; 13(3):375-93. PubMed ID: 12921388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and accurate prediction of degradant formation rates in pharmaceutical formulations using high-performance liquid chromatography-mass spectrometry.
    Darrington RT; Jiao J
    J Pharm Sci; 2004 Apr; 93(4):838-46. PubMed ID: 14999722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of shelf-life estimates for a human insulin pharmaceutical preparation using the matrix and full-testing approaches.
    Oliva A; Fariña J; Llabrés M
    Drug Dev Ind Pharm; 2003 May; 29(5):513-21. PubMed ID: 12779281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equivalence tests for shelf life and average drug content in stability studies.
    Djira GD; Hothorn LA; Tsong Y
    J Biopharm Stat; 2008; 18(5):985-95. PubMed ID: 18781530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.